Across CCLE and GDSC cell-line panels, response to EPZ5676 is significantly associated with the shRNA pathway dependency of multiple pathways, with BONE cell lines showing a particularly strong set of associations.
The most reproducible EPZ5676 response-associated pathways across cancer lineages are Positive regulation of T cell proliferation, Mitochondrial tRNA modification, and Regulation of homotypic cell-cell adhesion, each associated with drug response in up to 9 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, EPZ5676 response versus Positive regulation of T cell proliferation shRNA pathway dependency in BONE (Pearson r = 0.81).